Gainers
- OpGen OPGN stock increased by 513.1% to $2.06 during Thursday's pre-market session. The market value of their outstanding shares is at $18.3 million.
- Reshape Lifesciences RSLS shares increased by 126.44% to $0.61. The market value of their outstanding shares is at $3.1 million.
- Atreca BCEL shares rose 124.57% to $0.53. The company's market cap stands at $20.8 million.
- Jaguar Health JAGX stock moved upwards by 110.74% to $0.51. The market value of their outstanding shares is at $9.7 million.
- Cardio Diagnostics Hldgs CDIO stock increased by 56.3% to $0.42. The market value of their outstanding shares is at $4.9 million.
- LogicMark LGMK shares moved upwards by 34.83% to $2.09. The market value of their outstanding shares is at $2.7 million.
Losers
- Tempest Therapeutics TPST shares declined by 40.1% to $5.85 during Thursday's pre-market session. The market value of their outstanding shares is at $77.9 million.
- Agape ATP ATPC stock declined by 34.07% to $1.2. The company's market cap stands at $90.5 million.
- Phio Pharma PHIO stock declined by 33.85% to $1.72. The market value of their outstanding shares is at $3.8 million.
- RVL Pharmaceuticals RVLP shares declined by 31.64% to $0.11. The market value of their outstanding shares is at $11.9 million.
- T2 Biosystems TTOO stock decreased by 24.39% to $0.23. The company's market cap stands at $78.1 million.
- Longeveron LGVN stock declined by 17.94% to $1.51. The company's market cap stands at $31.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CDIOCardio Diagnostics Holdings Inc
$0.520010.4%
JAGXJaguar Health Inc
$0.8500-3.55%
LGMKLogicMark Inc
$0.25930.15%
LGVNLongeveron Inc
$1.59-2.95%
OPGNOpGen Inc
--%
PHIOPhio Pharmaceuticals Corp
$1.72-%
RSLSReshape Lifesciences Inc
$1.22-0.81%
TPSTTempest Therapeutics Inc
$0.8900-1.87%
TTOOT2 Biosystems Inc
$0.1121-51.5%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in